Robin Sherrington
CIK 0001619962
EVP, Strategy & Innovation
Filings
6
Latest Mar 12, 2024
Issuers covered
1
Showing
6 of 6
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 33% | -6.1% | -13.0% | +7.7% | -13.0% |
| 90 days | 6 | 100% | +10.7% | +7.4% | +17.3% | +7.4% |
| 180 days | 6 | 33% | -14.6% | -28.4% | +13.0% | -28.4% |
| 365 days | 6 | 33% | -8.2% | -22.8% | +20.9% | -22.8% |
Issuers
Companies where Robin Sherrington has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 6 | Mar 12, 2024 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|